RAPP

Rapport Therapeutics, Inc. Common Stock

40.45

USD

-1.50

-3.58%

Sep 18, 15:59 UTC -4

Closed

After-Market

40.48

+0.03

+0.07%

Rapport Therapeutics, Inc. Common Stock Profile

About

Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.

Info & Links

CEO

Abraham N. Ceesay

Headquarters

99 HIGH STREET, SUITE 2100
BOSTON, MA 02110, UNITED STATES

Auditor

PricewaterhouseCoopers LLP

Share holders

Employees

Rapport Therapeutics, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.94B

Enterprise Value

1.88B

Enterprise Value/EBITDA(ttm)

-12.24

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

4.57

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

25.00%

Operating Margin(ttm)

Profit Margin(ttm)

-24.82%

Return on Equity(ttm)

-29.02%

Return on Invested Capital(ttm)

-29.83%

Return on Assets(ttm)

-27.37%

Income Statement

Revenue(ttm)

20.00M

Revenue Per Share(ttm)

0.42

Gross Profit(ttm)

20.00M

EBITDA(ttm)³

-153.44M

Net Income Available to Common(ttm)

-137.16M

Diluted EPS(ttm)

-3.04

Share Statistics

Beta (5Y Monthly)

1.02

52-Week Change

53.80%

S&P 500 52-Week Change

17.10%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

47.98M

Dividend Yield

0.00%

Float⁴

41.99M

% Held by Insiders

12.48%

% Held by Institutions

Balance Sheet

Total Cash(mrq)

436.18M

Total Cash Per Share(mrq)

9.09

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

15.72%

Quick Ratio(mrq)

15.72%

Book Value Per Share(mrq)

8.82

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.15

Free Cash Flow(ytd)

-54.49M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.